AMALGAMATED BANK - GALENA BIOPHARMA INC ownership

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q3 2016$7,000
-12.5%
19,454
+0.5%
0.00%
Q2 2016$8,000
-65.2%
19,348
+14.1%
0.00%
-100.0%
Q1 2016$23,0000.0%16,951
+9.0%
0.00%
-33.3%
Q4 2015$23,000
-14.8%
15,548
-7.9%
0.00%0.0%
Q3 2015$27,000
-3.6%
16,883
+0.9%
0.00%0.0%
Q2 2015$28,000
+40.0%
16,731
+14.2%
0.00%
+50.0%
Q1 2015$20,000
+17.6%
14,651
+27.1%
0.00%
-33.3%
Q4 2014$17,000
-29.2%
11,524
+0.1%
0.00%
-25.0%
Q3 2014$24,000
-31.4%
11,507
-0.1%
0.00%
-20.0%
Q2 2014$35,000
+16.7%
11,516
-3.8%
0.01%0.0%
Q1 2014$30,000
-43.4%
11,967
+12.6%
0.01%
-44.4%
Q4 2013$53,00010,6310.01%
Other shareholders
GALENA BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Hoxton Financial, Inc. 50,000$74,0000.04%
Alyeska Investment Group, L.P. 1,593,277$2,342,0000.02%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 31,000$46,0000.02%
GROUP ONE TRADING, L.P. 1,346,904$1,980,0000.02%
Matisse Capital 17,000$25,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 15,000$22,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 12,150$18,0000.01%
EQUITEC SPECIALISTS, LLC 19,700$29,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 153,375$225,0000.00%
OPPENHEIMER & CO INC 94,300$138,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders